摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester | 616200-89-6

中文名称
——
中文别名
——
英文名称
7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester
英文别名
Methyl 7-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-oxochromene-3-carboxylate
7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester化学式
CAS
616200-89-6
化学式
C23H19NO6
mdl
——
分子量
405.407
InChiKey
PIVRJBXWRRRQRB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    30
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    87.9
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Benzopyran compounds, process for preparing the same and their use
    申请人:Yang Yushe
    公开号:US20060178405A1
    公开(公告)日:2006-08-10
    The invention relates to the benzopyran compounds of formula (I), or the salts thereof, in which, the bond between 3 and 4 positions is a single or double bond; R 1 represents a hydrogen atom or a C 1-6 alkyl that can be substituted; R 2 represents a hydrogen atom, a C 1-6 alkyl that can be substituted or an aromatic carbocyclic or aromatic heterocyclic group that can be substituted. The invention also relates to a process for preparing such compounds or their salts as well as the use of such compounds or their salts in the preparation of the medicine against type II diabetes mellitus.
    本发明涉及式(I)的苯并吡喃化合物或其盐,其中3和4位置之间的键为单键或双键;R1表示氢原子或可被取代的C1-6烷基;R2表示氢原子,可被取代的C1-6烷基或可被取代的芳香环烷基或芳香杂环基。本发明还涉及制备这种化合物或其盐的方法,以及使用这种化合物或其盐制备针对II型糖尿病的药物。
  • BENZOPYRAN COMPOUNDS, PROCESS FOR PREPARING THE SAME AND THEIR USE
    申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    公开号:EP1598345A1
    公开(公告)日:2005-11-23
    The invention relates to the benzopyran compounds of formula (I), or the salts thereof, in which, the bond between 3 and 4 positions is a single or double bond; R1 represents a hydrogen atom or a C1-6 alkyl that can be substituted; R2 represents a hydrogen atom, a C1-6 alkyl that can be substituted or an aromatic carbocyclic or aromatic heterocyclic group that can be substituted. The invention also relates to a process for preparing such compounds or their salts as well as the use of such compounds or their salts in the preparation of the medicine against type II diabetes mellitus.
    本发明涉及式(I)的苯并吡喃化合物或其盐,其中,3-4位之间的键为单键或双键;R1代表氢原子或可被取代的C1-6烷基;R2代表氢原子、可被取代的C1-6烷基或可被取代的芳香碳环或芳香杂环基团。本发明还涉及制备此类化合物或其盐的工艺,以及此类化合物或其盐在制备 II 型糖尿病药物中的用途。
  • EP1598345
    申请人:——
    公开号:——
    公开(公告)日:——
  • US7456205B2
    申请人:——
    公开号:US7456205B2
    公开(公告)日:2008-11-25
  • [EN] PPAR-ALPHA AGONISTS FOR TREATING MITOCHONDRIAL DISEASES<br/>[FR] AGONISTES DU RÉCEPTEUR PPAR-ALPHA POUR LE TRAITEMENT DE MALADIES MITOCHONDRIALES
    申请人:MITOBRIDGE INC
    公开号:WO2017044551A1
    公开(公告)日:2017-03-16
    Provided herein are methods for increasing PPARalpha activity and methods for treating PPARalpha related diseases (e.g., mitochondrial diseases).
查看更多